Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Oncogene
|
April 27, 2018
APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
Shixiang Wang, Mingming Jia, Zaoke He, et al.
Elife
|
November 27, 2019
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
Shixiang Wang, Zaoke He, Xuan Wang, et al.
International Journal of Cancer
|
April 12, 2019
The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients' sex
Shixiang Wang, Jing Zhang, Zaoke He, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
Identification of a RIPK2-Regulated Gene Signature as a Candidate Biomarker for RIPK2 Activity and Prognosis in Prostate Cancer
Ahmed M Elgehama, Qian Yang, Zaoke He, et al.
British Journal of Haematology
|
August 19, 2021
Ggct (γ-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival
Zaoke He, Xiaoqin Sun, Shixiang Wang, et al.
Translational Oncology
|
May 17, 2026
A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association
Ahmed M Elgehama, Qian Yang, Jaceline Gislaine Pires Sanches, et al.
Plos Genetics
|
May 4, 2021
Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes
Shixiang Wang, Huimin Li, Minfang Song, et al.
Iscience
|
August 11, 2019
Ras Downstream Effector GGCT Alleviates Oncogenic Stress
Zaoke He, Shixiang Wang, Yuanyuan Shao, et al.
Cancers
|
September 9, 2022
Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
Xiangyu Zhao, Yuxing Chen, Xiaoqin Sun, et al.
Iscience
|
April 14, 2021
Pan-cancer noncoding genomic analysis identifies functional <i>CDC20</i> promoter mutation hotspots
Zaoke He, Tao Wu, Shixiang Wang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Oncogene
|
April 27, 2018
APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
Shixiang Wang, Mingming Jia, Zaoke He, et al.
Elife
|
November 27, 2019
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
Shixiang Wang, Zaoke He, Xuan Wang, et al.
International Journal of Cancer
|
April 12, 2019
The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients' sex
Shixiang Wang, Jing Zhang, Zaoke He, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
Identification of a RIPK2-Regulated Gene Signature as a Candidate Biomarker for RIPK2 Activity and Prognosis in Prostate Cancer
Ahmed M Elgehama, Qian Yang, Zaoke He, et al.
British Journal of Haematology
|
August 19, 2021
Ggct (γ-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival
Zaoke He, Xiaoqin Sun, Shixiang Wang, et al.
Translational Oncology
|
May 17, 2026
A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association
Ahmed M Elgehama, Qian Yang, Jaceline Gislaine Pires Sanches, et al.
Plos Genetics
|
May 4, 2021
Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes
Shixiang Wang, Huimin Li, Minfang Song, et al.
Iscience
|
August 11, 2019
Ras Downstream Effector GGCT Alleviates Oncogenic Stress
Zaoke He, Shixiang Wang, Yuanyuan Shao, et al.
Cancers
|
September 9, 2022
Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
Xiangyu Zhao, Yuxing Chen, Xiaoqin Sun, et al.
Iscience
|
April 14, 2021
Pan-cancer noncoding genomic analysis identifies functional <i>CDC20</i> promoter mutation hotspots
Zaoke He, Tao Wu, Shixiang Wang, et al.
Page
of 1